The market expansion is primarily fueled by the increasing incidence of venous thromboembolism (VTE), deep vein thrombosis (DVT), pulmonary embolism (PE), and other blood-clotting disorders worldwide.

Researchers have found in a new study that using an age-adjusted D-dimer cutoff can safely rule out deep vein thrombosis and ...

A doctor failed to see test results that should have alerted them to Sue Howells's blood clot, an inquest hears.

"It was incredibly frightening. I had never felt so close to something life-threatening before," Nikki Bahan, a mom of three, ...

A mum-to-be discovered she had a one-in-a-million cancer after her fiancé refused to ignore the symptoms.

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Q1 2026 Earnings Call Transcript February 5, 2026 Arrowhead Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $0.22 EPS, expectations ...

By David Bautz, PhD NASDAQ:ARWR READ THE FULL ARWR RESEARCH REPORT Business Update First Commercial Sales of REDEMPLO® ...

A PFAS-remediation project using sustainably manufactured granulated activated carbon for drinking water demonstrates how ...

Dr. Olivia Greenspan, ND RN Abstract Structured risk factor modification and longitudinal lifestyle care can improve atrial ...

An expert said lab analysis of gloves found near Nancy Guthrie’s home could produce results within days. As the Nancy Guthrie abduction case stretches into a third week, investigators — and a public ...

“Bad,” or LDL, cholesterol is a major risk factor for heart disease and most people are screened for it as part of their yearly physicals ...

A clinical trial led by Kirby Institute at UNSW Sydney has found that point-of-care testing for hepatitis B DNA is as effective as traditional laboratory testing, paving the way for faster diagnosis ...